NCT07494045Phase 2Recruiting

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants

Study sponsor: OPKO Health, Inc. · OPK

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-10Estimated
Enrollment · participants40Estimated
Source updated2026-08-20Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source